Literature DB >> 8988758

Application of the Roche Amplicor Mycobacterium tuberculosis (PCR) test to specimens other than respiratory secretions.

R F D'Amato1, L H Hochstein, P M Colaninno, M Scardamaglia, K Kim, A J Mastellone, R C Patel, S Alkhuja, V J Tevere, A Miller.   

Abstract

The ability of the Roche AMPLICOR Mycobacterium tuberculosis (MTB) test to detect M. tuberculosis in specimens other than respiratory secretions was evaluated. A total of 249 specimens from 219 patients were tested. Of these, 12 specimens grew isolates of the M. tuberculosis complex and four grew isolates of the M. avium complex. The AMPLICOR MTB test was positive for 10 of the 12 specimens which grew M. tuberculosis and for three specimens which were culture negative. Two of the latter specimens were from patients with a clinical diagnosis of tuberculosis and with multiple sputum specimens which grew M. tuberculosis. Four specimens grew M. avium complex isolates, and all yielded negative AMPLICOR MTB test results. The sensitivity, specificity, and positive and negative predictive values for the AMPLICOR MTB test were 85.7%, 99.5%, 92.3%, and 99.1%, respectively. Our data indicate that the AMPLICOR MTB test will permit the rapid detection of M. tuberculosis in specimens other than respiratory secretions.

Entities:  

Mesh:

Year:  1996        PMID: 8988758     DOI: 10.1016/0732-8893(95)00256-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  4 in total

1.  Performance of an IS6110-based PCR assay and the COBAS AMPLICOR MTB PCR system for detection of Mycobacterium tuberculosis complex DNA in human lymph node samples.

Authors:  Dagmar Rimek; Sachin Tyagi; Reinhard Kappe
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

2.  Prevalence of suspected tuberculosis in the Kingdom of Saudi Arabia according to conventional and molecular methods.

Authors:  Ali Z Al Watban; Ali A Al Salamah; Mohamed G El Faki
Journal:  J Family Community Med       Date:  2014-09

3.  Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens.

Authors:  Christine C Ginocchio
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 4.  Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis.

Authors:  Madhukar Pai; Laura L Flores; Alan Hubbard; Lee W Riley; John M Colford
Journal:  BMC Infect Dis       Date:  2004-02-23       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.